Get the latest Science News and Discoveries

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of RET

RET

Photo of Pralsetinib

Pralsetinib

Related news:

Targeted therapy pralsetinib safely effectively treats lung and thyroid cancers with RET alterations

« NASA's massive moon rocket will roll out earlier than planned

Concise synthesis of pleurotin »